Kiyotani, K., Mushiroda, T., Imamura, C. K., Hosono, N., Tsunoda, T., Kubo, M., . . . Zembutsu, H. (2010). Significant Effect of Polymorphisms in CYP2D6 and ABCC2 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients. J Clin Oncol.
استشهاد بنمط شيكاغوKiyotani, Kazuma, et al. "Significant Effect of Polymorphisms in CYP2D6 and ABCC2 On Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients." J Clin Oncol 2010.
MLA استشهادKiyotani, Kazuma, et al. "Significant Effect of Polymorphisms in CYP2D6 and ABCC2 On Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients." J Clin Oncol 2010.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.